A central question has been answered regarding a protein that plays an essential role in the bacterial immune system and is fast becoming a valuable tool for genetic engineering. A team of researchers has determined how the bacterial enzyme known as Cas9, guided by RNA, is able to identify and degrade foreign DNA during viral infections, as well as induce site-specific genetic changes in animal and plant cells.
Researchers have discovered a potential treatment for a viral infection that causes potentially fatal brain swelling and paralysis in children. The findings also point to possible treatments for related viruses including those that cause common cold symptoms. The virus, called enterovirus 71 (EV71), causes yearly outbreaks of hand, foot and mouth disease in Southeast Asian countries, including China and Malaysia.
By letting DNA strands grow together with gold, scientists in Finland have developed a new concept for super-sensitive disease diagnostics. The method relies on growth of a DNA strand over a narrow gap between two electrodes in an electric circuit. The strand will only grow if a certain DNA molecule has bound to the surface of one electrode, which makes it possible to build diagnostic tests for detection of that specific DNA molecule.
Forget being sneezed on: Government scientists are deliberately giving dozens of volunteers the flu by squirting the live virus straight up their noses. It may sound bizarre, but the rare type of research is a step in the quest for better flu vaccines. It turns out that how the body fends off influenza remains something of a mystery.
People infected with HIV can stave off the symptoms of AIDS thanks to drug cocktails that mainly target three enzymes produced by the virus, but resistant strains pop up periodically. Researchers have now focused on a fourth protein, Nef, that hijacks host proteins and is essential to HIV’s lethality. By blocking the part of a key host protein to which Nef binds, it may be possible to slow or stop HIV.
An international team of scientists has discovered that two of the world’s most devastating pandemics, the plague of Justinian and the Black Death, each responsible for killing as many as half the people in Europe, were caused by distinct strains of the same pathogen. Because these plagues were hundreds of years apart, the findings suggest a new strain of bubonic plague could emerge again in humans in the future.
Using a novel high-throughput screening process, scientists have, for the first time, identified molecules with the potential to block the accumulation of a toxic eye protein that can lead to early onset of glaucoma. Glaucoma is a group of diseases that can damage the eye’s optic nerve and cause vision loss and blindness. Elevated eye pressure is the main risk factor for optic nerve damage.
Four Univ. of Washington School of Dentistry faculty members have received a patent for a new way of using titanium-based materials to fight oral bacteria. The patent culminates several years of work in which the group studied a novel class of substances called titanates and peroxotitanates, which can inhibit bacterial growth when bound to metal ions.
Brian imaging experiments have revealed for the first time how ecstasy produces feelings of euphoria in users. The findings hint at ways that ecstasy, or MDMA, might be useful in the treatment of anxiety and post-traumatic stress disorder. MDMA has been a popular recreational drug since the 1980s, but there has been little research on which areas of the brain it affects.
Exposing skin to sunlight may help to reduce blood pressure and, thus, cut the risk of heart attack and stroke, a recently published study suggests. Research carried out at the Univs. of Southampton and Edinburgh shows that sunlight alters levels of the small messenger molecule, nitric oxide (NO) in the skin and blood, reducing blood pressure.
Scientists at The Scripps Research Institute have demonstrated the power of a new drug discovery technique, which allows them to find, relatively quickly and cheaply, antibodies that have a desired effect on cells. The TSRI scientists used the technique to discover two antibodies that protect human cells from a cold virus.
Nearly 8 million Americans suffer from post traumatic stress disorder (PTSD), a condition marked by severe anxiety stemming from a traumatic event such as a battle or violent attack. Many patients undergo psychotherapy. However, Massachusetts Institute of Technology neuroscientists have now shown that they can extinguish well-established traumatic memories in mice by giving them a type of drug called an HDAC2 inhibitor.
A small, preliminary study using gene therapy to treat a rare form of blindness is promising and could trigger similar efforts for other causes of vision loss, British doctors say. They studied just six patients. Of those, two have had dramatic improvements in their vision and none has reported any serious side effects. The study was only designed to test the treatment's safety, not its effectiveness.
The controversial notion that being overweight might actually be healthier for some people with diabetes seems to be a myth, researchers report. A major study finds there's no survival advantage to being large, and a disadvantage to being very large. More than 24 million Americans have diabetes, mostly Type 2, the kind that is on the rise because of obesity. About two-thirds of U.S. adults are overweight, including one-third who are obese.
A panel of federal experts has recommended approval for an experimental blood thinner from Merck despite serious side effects including internal bleeding. The Food and Drug Administration's panel of cardiology experts voted 10-1 Wednesday in favor of approving the pill vorapaxar to help prevent blood clots in patients with a history of heart attacks.
The prevalence of Lyme disease varies greatly between different locales throughout the Northeast, even though the deer ticks that transmit Lyme bacterium are common throughout the entire region. A new study by researchers at the Yale School of Medicine suggests an unusual explanation to the mystery: differences in the makeup of microbes in the guts of the ticks.
Researchers at the Univ. of Delaware have developed a “smart” hydrogel that can deliver medicine on demand, in response to mechanical force. Over the past few decades, smart hydrogels have been created that respond to pH, temperature, DNA, light and other stimuli.
A world of cloak-and-dagger pharmaceuticals has come a step closer with the development of stealth compounds programmed to spring into action when they receive the signal. Researchers in the U.K. have designed and tested large molecular complexes that will reveal their true identity only when they’ve reached their intended target, like disguised saboteurs working deep behind enemy lines.
Scientists from the Florida campus of The Scripps Research Institute have described a pair of drug candidates that advance the search for new treatments for pain, addiction and other disorders. The two new drug scaffolds offer researchers novel tools that act on a demonstrated therapeutic target, the kappa opioid receptor (KOR), which is located on nerve cells and plays a role in the release of the neurotransmitter dopamine.
The parasites that cause malaria are exquisitely adapted to the various hosts they infect; so studying the disease in mice doesn’t necessarily reveal information that could lead to drugs effective against human disease. Now, a team of researchers has developed a strain of mice that mimics most features of the human immune system and can be infected with the most common human form of the malaria parasite, known as Plasmodium falciparum.
Duke Univ. scientists have taken aim at what may be an Achilles' heel of the HIV virus. Combining expertise in biochemistry, immunology and advanced computation, researchers at Duke have determined the structure of a key part of the HIV envelope protein, the gp41 membrane proximal external region (MPER), which previously eluded detailed structural description.
HIV antiviral therapy lets infected people live relatively healthy lives for many years, but the virus doesn’t go away completely. If treatment stops, the virus multiplies again from hidden reservoirs in the body. Now, investigators from the Massachusetts General Hospital and the Ragon Institute may have found HIV’s viral hiding place—in a small group of recently identified T-cells with stem cell-like properties.
Scientists have discovered how the element sodium influences the signaling of a major class of brain cell receptors, known as opioid receptors. The discovery, from The Scripps Research Institute and the Univ. of North Carolina, suggests new therapeutic approaches to a host of brain-related medical conditions.
A new porous structure under development in German possesses essential properties of natural bone marrow and can be used for the reproduction of stem cells in the laboratory. The specific reproduction of these hematopoietic cells outside the body might facilitate new therapies for leukemia in a few years.
Harvard Univ. stem cells scientists at Brigham and Women’s Hospital and Massachusetts Institute of Technology can now engineer cells that are more easily controlled following transplantation, potentially making cell therapies, hundreds of which are currently in clinical trials across the U.S., more functional and efficient.